Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency
- 9 September 2019
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (42) , 21150-21159
Abstract
Significance: Systemically administered lipid nanoparticles (LNPs) targeting the liver were able to express the cytoplasmic enzyme arginase 1 (ARG1) in a conditional knockout model of ARG1 deficiency. Metabolically, this resulted in maintaining normal plasma ammonia and arginine, preventing the build-up of excessive hepatic arginine, and obviated the development of guanidino compounds, a hallmark of this enzyme deficiency. Unlike controls, repeat dosing of LNPs encapsulating human codon-optimized ARG1 messenger RNA led to long-term survival without evidence of toxicity, restoration of ureagenesis, and the ability to handle toxic ammonia loading. These findings have implications for therapy of ARG1 deficiency, which is presently inadequately treated and leads to progressive neurological decline.Keywords
Funding Information
- HHS | National Institutes of Health (5 R01 NS100979)
This publication has 47 references indexed in Scilit:
- The incidence of urea cycle disordersMolecular Genetics and Metabolism, 2013
- AAV-based neonatal gene therapy for hemophilia A: long-term correction and avoidance of immune responses in miceGene Therapy, 2012
- Expression of therapeutic proteins after delivery of chemically modified mRNA in miceNature Biotechnology, 2011
- RH10 provides superior transgene expression in mice when compared with natural AAV serotypes for neonatal gene therapyThe Journal of Gene Medicine, 2010
- Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemiaMolecular Genetics and Metabolism, 2010
- Short-term Correction of Arginase Deficiency in a Neonatal Murine Model With a Helper-dependent Adenoviral VectorMolecular Therapy, 2009
- Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscleBMC Medical Genetics, 2007
- Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heartNature Biotechnology, 2005
- Fetal and neonatal gene therapy: benefits and pitfallsGene Therapy, 2004
- Characterization of the Hepatic Glutaminase Promoter1997